JANUVIA - 0006-0221-31 - (sitagliptin)

Alphabetical Index


Drug Information of JANUVIA

Product NDC: 0006-0221
Proprietary Name: JANUVIA
Non Proprietary Name: sitagliptin
Active Ingredient(s): 25    mg/1 & nbsp;   sitagliptin
Administration Route(s): ORAL
Dosage Form(s): TABLET, FILM COATED
Coding System: National Drug Codes(NDC)

Labeler Information of JANUVIA

Product NDC: 0006-0221
Labeler Name: Merck Sharp & Dohme Corp.
Product Type: HUMAN PRESCRIPTION DRUG
FDA Application Number: NDA021995
Marketing Category: NDA
Start Marketing Date: 20061016

Package Information of JANUVIA

Package NDC: 0006-0221-31
Package Description: 30 TABLET, FILM COATED in 1 BOTTLE (0006-0221-31)

NDC Information of JANUVIA

NDC Code 0006-0221-31
Proprietary Name JANUVIA
Package Description 30 TABLET, FILM COATED in 1 BOTTLE (0006-0221-31)
Product NDC 0006-0221
Product Type Name HUMAN PRESCRIPTION DRUG
Non Proprietary Name sitagliptin
Dosage Form Name TABLET, FILM COATED
Route Name ORAL
Start Marketing Date 20061016
Marketing Category Name NDA
Labeler Name Merck Sharp & Dohme Corp.
Substance Name SITAGLIPTIN PHOSPHATE
Strength Number 25
Strength Unit mg/1
Pharmaceutical Classes Dipeptidyl Peptidase 4 Inhibitor [EPC],Dipeptidyl Peptidase 4 Inhibitors [MoA]

Complete Information of JANUVIA


General Information